UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. Headquartered in Brussels (Belgium), the company relies on a team of 8.700 people, a strong market presence in 40 countries, € 3 billon in revenue (2013) and numerous strategic partnerships across the industry.
UCB de México SA de CV
Homero 440 – Piso 7
Col. Chapultepec Morales, Del. Miguel Hidalgo
CP 11570 México DF
Tel: +52 (55) 9159 6868